Sectra AB
STO:SECT B
Sectra AB
STO:SECT B
Price:
227.4 SEK
-1.73%
Updated:
Jun 6, 2024
P/S
Price to Sales
Price to Sales
26.7
Current
17.2
Median
2.4
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=26.7
Market Cap
/
43.8B
Revenue
1.6B
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| SE |
|
Sectra AB
STO:SECT B
|
43.8B SEK | 26.7 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
29.3B USD | 11.8 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.8B AUD | 87.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.6 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
5.3B USD | 11.2 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.5B USD | 6.8 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
3.2B USD | 4.1 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.7 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.7 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
15.4
2-Years Forward
P/S
13
3-Years Forward
P/S
11.2
You don't have any saved screeners yet
